Literature DB >> 11445222

Workshop studies on monoclonal antibodies in the myeloid panel with CD11 specificity.

J Domínguez1, B Alvarez, F Alonso, E Thacker, K Haverson, K McCullough, A Summerfield, A Ezquerra.   

Abstract

Several putative anti-human and swine CD11-specific monoclonal antibodies (mAbs) were included in the myeloid section of the Third International Swine CD Workshop. Failure of clustering analysis to group these mAbs together prompted additional analyses to define the specificities of these mAb. Combination of one and two-color flow cytometry (FCM) and immunoprecipitation (IP) allowed the definition of the mAb into three CD11 groups. Cellular distribution of the molecules recognized by anti-human CD11b and c mAbs on swine cells proved to be significantly different from that found in humans.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11445222     DOI： 10.1016/s0165-2427(01)00286-0

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN： 0165-2427            Impact factor:   2.046


  14 in total

1.  Porcine peripheral blood dendritic cells and natural interferon-producing cells.

Authors:  Artur Summerfield; Laurence Guzylack-Piriou; Alexander Schaub; Carlos P Carrasco; Valerie Tâche; Bernard Charley; Kenneth C McCullough
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

2.  Phenotypic and functional heterogeneity of porcine blood monocytes and its relation with maturation.

Authors:  Sonia Chamorro; Concepción Revilla; Belén Alvarez; Fernando Alonso; Angel Ezquerra; Javier Domínguez
Journal:  Immunology       Date:  2005-01       Impact factor: 7.397

3.  Innate immune responses to human rotavirus in the neonatal gnotobiotic piglet disease model.

Authors:  Ana M González; Marli S P Azevedo; Kwonil Jung; Anastasia Vlasova; Wei Zhang; Linda J Saif
Journal:  Immunology       Date:  2010-10       Impact factor: 7.397

4.  Immunohistochemical markers for quantitative studies of neurons and glia in human neocortex.

Authors:  Lise Lyck; Ishar Dalmau; John Chemnitz; Bente Finsen; Henrik Daa Schrøder
Journal:  J Histochem Cytochem       Date:  2007-11-12       Impact factor: 2.479

5.  Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood.

Authors:  Ebbe Billmann Thorgersen; Anne Pharo; Karin Haverson; Anne K Axelsen; Peter Gaustad; Girish J Kotwal; Georgia Sfyroera; Tom Eirik Mollnes
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

6.  CD1- and CD1+ porcine blood dendritic cells are enriched for the orthologues of the two major mammalian conventional subsets.

Authors:  Jane C Edwards; Helen E Everett; Miriam Pedrera; Helen Mokhtar; Emanuele Marchi; Ferran Soldevila; Daryan A Kaveh; Philip J Hogarth; Helen L Johns; Javier Nunez-Garcia; Falko Steinbach; Helen R Crooke; Simon P Graham
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

7.  An Immunomodulatory Device Improves Insulin Resistance in Obese Porcine Model of Metabolic Syndrome.

Authors:  Angela J Westover; Kimberly A Johnston; Deborah A Buffington; H David Humes
Journal:  J Diabetes Res       Date:  2016-10-13       Impact factor: 4.011

Review 8.  Regenerative Medicine and Immunomodulatory Therapy: Insights From the Kidney, Heart, Brain, and Lung.

Authors:  Christopher J Pino; Angela J Westover; Kimberly A Johnston; Deborah A Buffington; H David Humes
Journal:  Kidney Int Rep       Date:  2018-01-05

9.  The food contaminant fumonisin B(1) reduces the maturation of porcine CD11R1(+) intestinal antigen presenting cells and antigen-specific immune responses, leading to a prolonged intestinal ETEC infection.

Authors:  Bert Devriendt; Me'lanie Gallois; Frank Verdonck; Yann Wache; Diane Bimczok; Isabelle P Oswald; Bruno M Goddeeris; Eric Cox
Journal:  Vet Res       Date:  2009-04-24       Impact factor: 3.683

10.  Porcine B Cell Subset Responses to Toll-like Receptor Ligands.

Authors:  Roman Othmar Braun; Sylvie Python; Artur Summerfield
Journal:  Front Immunol       Date:  2017-08-25       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.